DuraStat, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

DuraStat, Inc. - overview

About

Based in Texas, US, and founded in 2015, DuraStat, Inc. is a medical device company focused on precision suturing. In March 2019, DuraStat raised USD 4. 5 million in venture funding and in April 2022, it raised USD 5 million in Series B funding.

DuraStat was invented by Greg Anderson, MD and Mark Kurd, MD (Thomas Jefferson University and Rothman Institute) and developed for global scalability with Kevin Foley, MD (Semmes-Murphey) and Alex Lukianov. The company is led by CEO, Adam Azzara. The company offers its flagship dural repair product DuraStat, which is a surgical device with a new approach to precision suturing that eliminates wrist motion and allows for quick, atraumatic tissue approximation by minimizing tissue disruption. DuraStat not only decreases repair time but also alleviates stress by increasing any surgeon's ability and confidence to address sutured repairs.

The company plans to use the 2022 funding to leverage its expertise and intellectual property portfolio to launch an additional spine product by late 2022 with more coming to market throughout 2023.

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare, Surgical Devices

Website

www.durastat.com

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo